Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SurgiLance One-Step

This article was originally published in The Gray Sheet

Executive Summary

Safety lancet patent infringement ruling does not apply to the revised One-Step Plus version, which will remain available in the U.S., the firm says. SurgiLance is appealing a June 22 Atlanta federal court sales injunction against One-Step, which was voluntarily removed from the market in the spring after the Plus launch, the firm says. Owen Mumford, Inc. had charged that One-Step infringed its '249 patent. Launched in the U.S. in September 2000, One-Step generated 2003 sales of $6.3 mil., up 106%. The original One-Step remains available outside the U.S...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts